Bringing the fundamentals into focus…
Back to Nektar Therapeutics
How Nektar Therapeutics stacks up
NKTR · against 1,216 other Healthcare companies
Growth
2/ 100
Near the bottom of its peers.
Ranked #1,187 of 1,217 · scores higher than 2% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including NKTR · Click a bar to see the companies
Why growth scores 2?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 95% of peers. Revenue growth: -43.9% vs peer median 6.1%
- slower revenue growth over three years: weaker than 92% of peers. 3-year revenue growth: -15.7% vs peer median 5.8%
- Earnings per share growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = NKTR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NKTR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -43.9% | 6.1% | 5% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -15.7% | 5.8% | 8% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around NKTR| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,187 | 5M USD | 2 | 27 | |
| 1,187 | 725M USD | 2 | 19 | |
| 1,187 | 390.5B IDR (≈$24M) | 2 | 8 | |
| 1,187 | 366M CHF (≈$421M) | 2 | 23 | |
| 1,187 | 1.3B USD | 2 | 27 | |
| 1,199 | 12.7B CNY (≈$1.8B) | 1 | 20 | |
| 1,199 | 3.4B CNY (≈$482M) | 1 | 22 | |
| 1,199 | 327M USD | 1 | 11 | |
| 1,202 | 580M HKD (≈$74M) | 0 | 7 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score